Global Payer Evidence Generation Director

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

Søborg

Are you ready to drive the Payer Evidence Generation (PEG) strategy for Novo Nordisk Global Rare Disease? Do you have the expertise to develop evidence generation plans and support market access for our pipeline products? If you are passionate about driving value proposition and supporting payer dialogues, then this role might be perfect for you. Read on and apply today for a life-changing career.
The position
As a Global Payer Evidence Director in the Rare Blood Disorders team, you represent a compelling opportunity within the pharmaceutical industry. As a leader in healthcare, Novo Nordisk seeks individuals who are dedicated to influencing and shaping payer evidence strategies on a global scale. This pivotal role offers the chance to contribute to the company's mission of providing valuable evidence to payers, thereby ensuring access to innovative healthcare solutions worldwide. As a Global PEG Director, you will:
  • Set the Payer Evidence Generation (PEG) strategy and develop evidence generation plans to support market access for pipeline products and in-line brands in the Rare Blood Disorders TAs.
  • Identify evidence gaps and design PEG projects to mitigate gaps and substantiate the product value proposition.
  • Drive activities such as payer relevant endpoints in clinical trials, real-world evidence programs, patient costed pathways, epidemiology studies, and more.
  • Lead descriptive and statistical analysis from secondary data sources.
  • Manage ad hoc evidence requests from affiliates and support payer dialogues.
  • Lead internal and external training on Payer Evidence Generation.
  • Establish and maintain a network of stakeholders with influence on payer expectations and access needs.

  • Qualifications
    To be our new Global PEG Director, we are looking for a candidate with the following qualifications:
  • Minimum of six years of experience as PEG management (preferably) and/or HEOR and/or payer value communication, within the pharmaceutical industry or consultancy for the pharmaceutical industry.
  • Proven track record of impactful scientific publications, particularly peer-reviewed publications, is advantageous.
  • University master’s degree in a relevant field such as health economics, outcomes research, epidemiology, or statistics/biostatistics.
  • Fluent in written and spoken English with strong project and stakeholder management skills.
  • Demonstrated business acumen, strategic thinking, and a positive, "Can do" approach.
  • About the department
    In Novo Nordisk Rare Disease, we are responsible for the development, manufacturing, market access and distribution of high-quality therapeutics for people living with rare diseases like hemophilia or hormonal deficiencies. In Global Rare Disease Access and Pricing, we ensure that there is access to our rare disease products for the people around the world who need it.
    The department is an expanding, international, high performing team of dedicated professionals situated in Søborg, Denmark. Optimising market access, we ensure the continued success of the Novo Nordisk Rare Disease Portfolio when we develop and execute strong, evidence-based global access strategies. In close collaboration with key internal stakeholders, Global Rare Disease Access and Pricing establishes these strategies and key support tactics in the areas of pricing, reimbursement, health economics & outcomes research, value communication, and subsequently supports the implementation regionally and locally.
    Working at Novo Nordisk
    We don’t wait for a change. We drive it.
    We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact
    For further information, please contact Tal Waner, Senior Global Market Access Director, at [email protected] Deadline
    7 July 2024
    We will screen applications continuously, so don’t hesitate to submit it as soon as possible.
    You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.
    We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.


    Information og data

    Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".

    Arbejdsstedet er beliggende i Søborg.

    Jobbet er oprettet på vores service den 20.6.2024, men kan have været deaktiveret og genaktiveret igen.

    Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
    • Øvrige
    • Søborg

    Lignende jobs

    • Senior Associates og Managers til Transaction Advi...

      Fri kontakt
      Senior Associates og Managere til Transaction Advisory Service i København. Vi mærker en stigende efterspørgsel efter rådgivning i forbindelse med køb og salg af virksomheder, herunder finansiel due diligence. Derfor søger vi Senior Associates og Managere til vores TAS team på Østerbro.
      • Øvrige
      • København Ø
      Få mere info
    • Øvrige i Frederiksberg C

      Fri kontakt
      Se https://www.digitaldisruptionmedia.com/jobs/piccolinepiccolo-sges-snarest
      • Øvrige
      • Frederiksberg C
      Få mere info
    • Breakfast Manager, fuldtid, Scandic Webers

      Fri kontakt
      Er du ambitiøs, målrettet og ikke bange for at rydde vanetænkning af bordet, så tror vi på, at du er vores nye Breakfast Manager på Scandic Webers. Vi ved, at du ta’r ansvar og har ro i maven med det fulde overblik. Du er god til at organisere, købe ind, lede og dele din viden.
      • Øvrige
      • København
      Få mere info
    • Revenue Manager, Scandic Hotel A/S - Support Offic...

      Fri kontakt
      Brænder du for tal, strategi og optimering og har du lyst til at være en del af det danske Revenue Management Team hos Nordens førende hotelkæde? Så tror vi på, at du er vores nye Revenue Manager med interesse for analyse og tal på Scandic Support Office i København.
      • Øvrige
      • København
      Få mere info

    Statistik over udbudte jobs som øvrige i Søborg

    Herunder ser du udviklingen i udbudte øvrige i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.

    Se flere statistikker her:
    Statistik over udbudte øvrige i Søborg over tid

    Dato Alle jobs som øvrige
    26. november 2024 59
    25. november 2024 58
    24. november 2024 63
    23. november 2024 61
    22. november 2024 61
    21. november 2024 63
    20. november 2024 64
    19. november 2024 60
    18. november 2024 62
    17. november 2024 63
    16. november 2024 65
    15. november 2024 63
    14. november 2024 63
    13. november 2024 65
    12. november 2024 61
    11. november 2024 58
    10. november 2024 60
    9. november 2024 60
    8. november 2024 59
    7. november 2024 60
    6. november 2024 58
    5. november 2024 56
    4. november 2024 55
    3. november 2024 57
    2. november 2024 57
    1. november 2024 57
    31. oktober 2024 55
    30. oktober 2024 56
    29. oktober 2024 56
    28. oktober 2024 56
    27. oktober 2024 56